| Anti-Doping |
 | | Syringe |
Please see the dedicated website www.itftennis.com/antidoping for full information on the ITF Tennis Anti-Doping Programme.
Doping has been a part of sport for many years, with performance enhancing substances giving an unfair advantage over fellow competitors. Since the introduction of testing for these substances, there have been many high (and low) profile cases of sportsmen and women being found to have committed Doping Offences in a range of sports.
Why? Performance-enhancing substances or methods are used to provide an unfair advantage in both training and competition, by allowing players not only to perform better, but also to train longer, harder and more frequently. Such performance enhancements may include increased strength, power and stamina.
Why are they illegal? Doping undermines the integrity and violates the spirit of the sport while at the same time posing a health risk to the athlete.
Who is in charge of anti-doping? WADA (World Anti Doping Agency) was created in 1999 to promote, coordinate and monitor the fight against doping in sport in all its forms. WADA works together with national and international sporting organisations and governments to maintain clean and honest competition. The ITF manages the Tennis Anti-Doping Programme (TADP) on every playing level. In addition to Juniors, the events covered by the TADP include (without limitation) Grand Slam tournaments, Davis Cup and Fed Cup ties, the Olympic Tennis event, WTA Tour tournaments, ATP Tour tournaments, ITF Women’s Circuit tournaments, Challenger Series tournaments, Futures tournaments and Wheelchair events.
^ Back to Top
|
